adenosine diphosphate has been researched along with Venous Thrombosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; Li, Z; Liang, R; Liao, R; Xu, X; Zhang, B; Zhang, L | 1 |
| Anyanwu, AC; Chi, L; Desch, KC; Fukase, K; Gruca, M; Hyman, MC; Kanthi, Y; Kaskar, S; Liao, H; Mimura, T; Pinsky, DJ; Sheikh-Aden, H; Wakefield, TW; Yadav, V; Zhao, R | 1 |
| Chong, CM; Chu, IK; Cui, G; Guo, L; Hoi, MP; Lee, SM; Li, G; Quan, Q; Shan, L; Sun, Y; Wang, Y; Yu, P; Zhang, Z; Zhao, Y | 1 |
| Cakir, N; Demir, M; Orüm, H; Pamuk, GE; Pamuk, ON; Turgut, B | 1 |
| Xie, ML; Xue, J; Zhang, HQ; Zhang, KP; Zhu, LJ | 1 |
| Fu, L; Jiang, F; Jin, Y; Liu, J; Liu, W; Zhang, Y | 1 |
| Diao, XJ; Gong, GQ; He, GW; Xu, YG; Yang, WH; Yang, XZ | 1 |
| Eigenthaler, M; Kobsar, A; Lohmann, T; Sokolova, O; Wallaschofski, H | 1 |
| Imin, H; Moore, N; Tohti, I; Turdi, S; Tursun, M; Umar, A | 1 |
| Iwatani, Y; Kanakura, Y; Kuratsune, H; Nojima, J; Suehisa, E | 1 |
| Chen, C; El Sayed, HF; Kougias, P; Lin, PH; Okada, T; Rawat, A; Steinberg, JL; Yao, Q; Zhou, W | 1 |
| Cho, JS; Gloviczki, P; Miller, VM; Mozes, G; Rhodes, JM; Rolle, R | 1 |
| Hsiao, G; Lee, YM; Sheu, JR; Yen, MH | 1 |
1 review(s) available for adenosine diphosphate and Venous Thrombosis
| Article | Year |
|---|---|
Co-activation of platelets by prolactin or leptin--pathophysiological findings and clinical implications.
Topics: Adenosine Diphosphate; Arteriosclerosis; Female; Gene Expression; Humans; Leptin; P-Selectin; Platelet Activation; Pregnancy; Prolactin; Venous Thrombosis | 2004 |
12 other study(ies) available for adenosine diphosphate and Venous Thrombosis
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of nitric oxide releasing derivatives of dapagliflozin as potential anti-diabetic and anti-thrombotic agents.
Topics: Adenosine Diphosphate; Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Design; Glucose Tolerance Test; Glucosides; HEK293 Cells; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Molecular Structure; Nitric Oxide; Platelet Aggregation; Rabbits; Structure-Activity Relationship; Venous Thrombosis | 2018 |
Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Blood Platelets; Cell Adhesion; Chemotaxis, Leukocyte; Gene Expression Regulation; Gene Regulatory Networks; Hemorheology; Ligation; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Receptors, Purinergic P2Y1; Vasculitis; Vena Cava, Inferior; Venous Thrombosis; von Willebrand Factor | 2019 |
Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cell Adhesion Molecules; Chlorides; Disease Models, Animal; Enzyme Activation; Ferric Compounds; Fibrinolytic Agents; Gene Expression Regulation; Heme Oxygenase-1; Humans; Lactates; Microfilament Proteins; Models, Biological; P-Selectin; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Disulfide-Isomerases; Proteomics; Rats; Thrombosis; Venous Thrombosis | 2015 |
Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study.
Topics: Adenosine Diphosphate; Adult; Aneurysm; Behcet Syndrome; Blood Platelets; Female; Humans; Leukocytes; Male; Middle Aged; Monocytes; P-Selectin; Platelet Activation; Venous Thrombosis | 2010 |
Inhibitory effects of Qushuanling Capsule () on thrombus formation and platelet aggregation in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Aorta; Cerebral Infarction; Drugs, Chinese Herbal; Male; Middle Cerebral Artery; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane B2; Venous Thrombosis | 2013 |
Design, synthesis, and evaluation of 2-substituted ethenesulfonic acid ester derivatives as protein tyrosine phosphatase 1B inhibitors.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Esters; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |
Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |
Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Topics: Adenosine Diphosphate; Animals; Arteriovenous Shunt, Surgical; Dose-Response Relationship, Drug; Male; Models, Animal; Ocimum basilicum; Phytotherapy; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thrombin; Venous Thrombosis | 2006 |
The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Topics: Abortion, Habitual; Adenosine Diphosphate; Adolescent; Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Arterial Occlusive Diseases; Autoantibodies; Autoantigens; beta 2-Glycoprotein I; Child; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Phosphatidylserines; Platelet Activation; Pregnancy; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis | 2006 |
Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: effect of L-arginine on thrombogenicity and endothelial vasomotor function.
Topics: Adenosine Diphosphate; Angiography; Animals; Arginine; Bradykinin; Calcimycin; Disease Models, Animal; Endosonography; Endothelium, Vascular; Microscopy, Electron, Scanning; Nitroprusside; Serotonin; Swine; Thrombectomy; Venous Thrombosis | 2007 |
Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity.
Topics: Adenosine Diphosphate; Analysis of Variance; Animals; Calcimycin; Catheterization; Dogs; Endothelium, Vascular; Femoral Vein; Fibrin; Ionophores; Ligation; Male; Microscopy, Electron, Scanning; Nitric Oxide; Plasminogen Activators; Platelet Adhesiveness; Thrombectomy; Thrombolytic Therapy; Treatment Outcome; Ultrasonography, Doppler, Duplex; Urokinase-Type Plasminogen Activator; Vascular Patency; Vasodilator Agents; Vasomotor System; Venous Thrombosis | 2000 |
Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Pressure; Drug Evaluation, Preclinical; Fibrinolytic Agents; Injections, Intravenous; Mesenteric Arteries; Mesenteric Veins; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Radiation Injuries, Experimental; Reproducibility of Results; Thrombolytic Therapy; Vasodilator Agents; Venous Thrombosis | 2001 |